The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

EAST EASTPHARMA LTD GDR (EACH REPR 1 COM SHR)(REGS)



Income Statement  ($ m) 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Continuing Operations
Revenue  253.82 242.26 231.98 217.13 210.53
Operating Profit/(Loss)  -2.87 -7.78 29.50 14.47 16.33
Net Interest  6.20 10.07 13.55 13.77 18.26
Profit Before Tax  -2.87 -16.53 16.35 1.52 -1.96
Profit After Tax  -2.45 -18.06 11.60 1.06 -1.55
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  -2.45 -18.06 11.60 1.06 -1.55
Attributable to:
Minority Interests  1.21 2.38 -2.52 -1.59 -0.07
Equity Holders of Parent Company  -1.24 -15.68 9.08 -0.53 -1.62
 
Continuing EPS
Earnings per Share - Basic  -2.00¢ -23.00¢ 13.00¢ -1.00¢ -2.00¢
Earnings per Share - Diluted  -2.00¢ -23.00¢ 13.00¢ -1.00¢ -2.00¢
Earnings per Share - Adjusted  -2.00¢ -23.00¢ 13.00¢ -1.00¢ -2.00¢
Continuing and Discontinued EPS
Earnings per Share - Basic  -2.00¢ -23.00¢ 13.00¢ -1.00¢ -2.00¢
Earnings per Share - Diluted  -2.00¢ -23.00¢ 13.00¢ -1.00¢ -2.00¢
Earnings per Share - Adjusted  -2.00¢ -23.00¢ 13.00¢ -1.00¢ -2.00¢
 
Dividend per Share  0.00¢ 0.00¢ 0.00¢ 0.00¢ 0.00¢

Balance Sheet  ($ m) 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Assets
Non-Current Assets
Property, Plant & Equipment  133.50 126.88 137.88 125.87 117.00
Intangible Assets  189.55 172.48 180.23 174.66 181.47
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  2.84 2.16 1.42 0.96 0.55
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  35.18 27.26 28.65 22.69 24.17
  361.07 328.78 348.18 324.18 323.19
Current Assets
Inventories  94.00 63.97 75.06 77.39 76.18
Trade & Other Receivables  120.52 101.53 119.77 87.97 88.30
Cash at Bank & in Hand  12.87 14.69 18.16 34.01 23.33
Current Asset Investments  0.00 0.00 0.00 0.00 0.00
Other Current Assets  0.00 0.00 0.00 0.00 0.00
  227.39 180.19 212.99 199.37 187.81
 
Total Assets  588.46 508.97 561.17 523.55 511.01
 
Liabilities
Current Liabilities
Borrowings  -70.62 -82.18 -120.60 -78.29 -85.50
Other Current Liabilities  -76.60 -43.58 -39.22 -32.33 -31.00
  -147.22 -125.76 -159.82 -110.61 -116.50
 
Net Current Assets  80.17 54.43 53.18 88.76 71.31
 
Non-Current Liabilities
Borrowings  -28.77 -39.02 -30.23 -85.22 -85.05
Provisions  0.00 -3.09 -3.08 -2.33 -2.16
Other Non-Current Liabilities  -5.67 -6.11 -7.53 -7.08 -7.18
  -34.44 -48.22 -40.84 -94.63 -94.39
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -181.66 -173.98 -200.66 -205.24 -210.90
 
Net Assets  406.80 334.99 360.52 318.32 300.11
 
Capital & Reserves
Share Capital  338.25 338.25 338.25 338.25 338.25
Share Premium Account  99.77 99.77 99.77 99.77 99.77
Other Reserves  -12.07 -75.27 -58.83 -109.23 -128.81
Retained Earnings  -59.37 -75.04 -65.97 -66.50 -68.12
Shareholders Funds  366.58 287.71 313.23 262.30 241.10
 
Minority Interests/Other Equity  40.22 47.28 47.29 56.02 59.01
Total Equity  406.80 334.99 360.52 318.32 300.11

Ratios - based on IFRS 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Continuing Operations
PE Ratio - Adjusted  -0.43 -0.04 0.09 -1.15 -0.26
PEG - Adjusted  n/a n/a n/a n/a n/a
Earnings per Share Growth - Adjusted  n/a n/a n/a n/a n/a
Dividend Cover  n/a n/a n/a n/a n/a
Revenue Per Share  375.19¢ 358.11¢ 342.92¢ 320.95¢ 311.21¢
Pre-Tax Profit per Share  -4.25¢ -24.44¢ 24.17¢ 2.24¢ -2.89¢
Operating Margin  1.27% -11.84% 12.98% 7.04% 7.54%
Return on Capital Employed  1.04% -2.25% 8.95% 4.94% 5.60%
 
Continuing & Discontinued Operations
Dividend Yield  0.00% 0.00% 0.00% 0.00% 0.00%
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  261.69¢ 164.62¢ 196.60¢ 129.55¢ 88.16¢
Net Gearing  23.60% 37.02% 42.35% 49.37% 61.06%

Data is provided by Morningstar

Market

Company Information
Updated Monthly
Company address Clarendon House, 2 Church Street, Hamilton, HM11, Bermuda
Company website http://www.eastpharmalt...
Market cap(in millions)* £ 59.73
Listing/Admission to trading 18 Jul 2007
Trading service -
Market -
Listing category Standard GDRs
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
06-Jul-15
FTSE index -
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register -
Segment -
MiFID Status -
Exchange market size -
SEDOL -
ISIN number -



EASTPHARMA S share - fundamentals